Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and d ...

Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announced that the Company ...

Autolus Therapeutics plc (NASDAQ:AUTL) is one of the small-cap stocks with potential to rise 1000 percent. Unlike many biotech companies that are still waiting for their first approved product, ...

Autolus Therapeutics is back in focus as analysts adjust price targets around the early commercial rollout of Aucatyzl, with some highlighting a recent move to US$10 while others have trimmed ...

View Autolus Therapeutics Plc Sponsored ADR AUTL stock quote prices, financial information, real-time forecasts, and company news from CNN.

Shares of Autolus Therapeutics (NASDAQ: AUTL) were crashing 35.9% as of 10:34 a.m. ET on Friday. The steep decline came after the biopharmaceutical company announced the price of a public stock ...

Autolus Therapeutics AUTL and Cardinal Health CAH inked a partnership deal for managing the supply chain of the former’s next-generation CAR-T cell therapies. Autolus, a clinical-stage ...

CEO Christian Itin highlighted the strong progress made in 2024, with the successful U.S. approval and launch of AUCATZYL. The product was approved slightly ahead of schedule and without a required ...

Autolus Therapeutics (NASDAQ:AUTL) is gearing up to announce its quarterly earnings on Wednesday, 2025-11-12. Here's a quick overview of what investors should know before the release. Analysts are ...

Autolus Therapeutics plc (NASDAQ:AUTL) is one of the best stocks under $5 with highest upside potential. Autolus Therapeutics plc (NASDAQ:AUTL) received a Buy rating from Needham analyst Gil Blum on ...

Autolus plans to sell 75 million American depositary shares at a price of $2 each. The proceeds will be used to fund the development of the company's obe-cell cancer cell therapy. Autolus said that it ...